“…The positioning of BATF as an early, or pioneering, regulator of a diverse gene set impacting transcription events (Nfil3), post-transcriptional events (miR155gh), and cellular signaling (Wnt10a) is very exciting. While the negative impact of canonical WNT signaling on CSR was noted previously [36], a role for WNT10A expression was not, and the availability of recombinant WNT10A and WNT pathway inhibitors should facilitate future investigations of this pathway in CSR. Finally, as BATF, NFIL3 and miR155 are known regulators Th2, Th17 and Tfh cell differentiation and function [10,11,13,42,43], it is not surprising that the BATF targets studied here are also misregulated in Batf Z/ Z CD4+ T cells (Morman and Taparowsky, in preparation).…”